baber/WOPTO huggingface dataset:
Patent DK-0606391-T3 (DK)
Inventor: PALABRICA THERESA M
IPC: A61P9/08
Filed: 1992-09-30
Granted: 1999-05-03
Abstract: A method for inhibiting vascular narrowing at an intravascular site treated by angioplasty, endarterectomy or atherectomy, in natural and synthetic vascular grafts, in arteriovenous fistulas, at intravascular sites following deployment of vascular stents or cardiovascular devices, and at an intravascular site of platelet deposition is disclosed. The method comprises the step of administering a therapeutically effective amount of an anti-PADGEM antibody or an antibody homolog thereof that binds PADGEM.
Patent DK-0597406-T3 (DK)
Inventor: KNEILE KARL
IPC: B60S9/08
Filed: 1993-11-06
Granted: 1998-04-27
Abstract: The lifting support has a bearer (3) provided for fastening on a holder and a support (25, 26) which is mounted pivotably on the bearer (3). The support can be pivoted from a rest position into a support position. Engaging on the support (25, 26) is a driver (30) which is mounted pivotably on the bearer (3). In the pivoting process the driver (30) drives the support (25, 26) into one of the two positions. The driver (30) is a simple component which like the support (25, 26) is mounted pivotably on the bearer (3). The support (25, 26) serves to support mobile homes or caravans. <IMAGE>
Patent DK-0668024-T3 (DK)
Inventor: DELHOVREN NATHALIE
IPC: A23K1/20
Filed: 1994-01-24
Granted: 2001-06-25
Abstract: Sterilised animal feed (esp. pet food) prods. comprise meat-based chunks in a sauce or base. The chunks are prepd. from a mixt. of 55-85% meat and meat by-products, 10-25% cereals and 0-15% water. The chunks are irregular with clean-cut unbroken edges, where 97% of the chunks are larger than 5mm and 40-70% are not geometric cubes. Also claimed is the prepn. of the prod. by mixing the ingredients of the chunks, emulsifying the mixt., extruding and cooking the mixt., pre-cutting, cooling and cubing the prod., mixing the resulting chunks with the sauce or base, filling a container with the mixt., and sterilising the prod. The chunks are pref. prepd. from a mixt. of 58-68% meat and meat by-products, 16-25% cereals, 0-5% (esp. 2-5%) vegetable protein and 5-14% water. The chunks have a water content of 50-60% and are present in an amt. of 20-50%. The mixt. is emulsified at 15 degrees C or less and is extruded in the form of a sausage with a cross section that can be inscribed in a 20x20 mm square. The sausage is cooked at 80-95 degrees C, cut into 80-400 mm lengths, cooled to 10-40 degrees C, and fed randomly into a dicing machine.
Patent DK-0624594-T3 (DK)
Inventor: GLOMBIK HEINER DR
IPC: A61K31/58
Filed: 1994-05-02
Granted: 1999-12-13
Abstract: Monomeric bile acid derivatives of the formula I  Z-X-GS      I, in which GS, X and Z have the stated meanings, and processes for their preparation are described. The compounds have valuable pharmacological properties and can therefore be used as medicines.
Patent DK-0668326-T3 (DK)
Inventor: WOLTER HERBERT
IPC: C08L83/08
Filed: 1995-01-21
Granted: 2004-12-06
Abstract: Covalent-nucleophilic self-hardening systems (A) based on polymerisable and hydrolytically condensable and/or condensed Si cpds. consist of components 1 and 2 which opt. contain normal additives and fillers and opt. other copolymerisable monomers and/or oligomers and/or other hydrolytically condensable and/or condensed cpds. of Si and opt. of Al, Ti, Zr, B, P, Sn, Pb, transition metals, lanthanides or actinides. Component 1 contains Si cpd(s). of formula (I), opt. in (pre)condensed form: (XaRbSiÄ(R'A)cÜ(4-a-b))xB (I). A = O, S, PR'', POR'', NHCOO or NHCONR''; B = organic residue derived from a cpd. B' with at least one (for c = 1 nd A = NHCOO or NHCONR'') or at least 2 C=C double bonds and 5-50 atoms; R = alkyl, alkenyl, aryl, aralkyl or alkaryl; R' = alkylene, arylene or alkylene-arylene; R'' = H, alkyl or aryl; X = H, halo, OH, alkoxy, acyloxy, alkylcarbonyl, alkoxycarbonyl or NR''2; a = 1, 2 or 3; b = 0, 1 or 2; c = 0 or 1; x = a no. corresp. to the max. no. of double bonds in cpd. B' minus 1 or equal to the no. of double bonds in B' when c = 1 and A = NHCOO or NHCONR'' (the above alkyl or alkenyl gps. are opt. substd. linear, branched or cyclic gps. with 1 or 2 to 20C atoms, aryl = opt. substd. phenyl, naphthyl or biphenyl and the other gps. are derived from these). Component 2 contains cpd(s). with at least one substd. and/or unsubstd. amino gp.
Patent DK-0716901-T3 (DK)
Inventor: SCHOEN UWE
IPC: B23Q11/08
Filed: 1995-11-03
Granted: 2000-03-20
Abstract: To prevent elongation of a covering tape or ribbon (25) extending over an elongated opening (34) in an elongated base body (2) over which a movable element (3) can slide, the tape or ribbon is retained at preferably both of its ends, by a reverse motion, or one-way lock (50,52). In the simplest form, this reverse-motion lock (50,52) is formed by a leaf spring (63) extending at an acute angle with respect to the tape or ribbon; the tape or ribbon is backed up by bridge-like counter element (54) bridging over the elongated opening (34). If the tape or ribbon stretches, for example due to friction upon movement of the movable element (3) heating, or aging, and the movable element pushes the tape or ribbon in form of a bulge towards a terminal position, it can slide beneath the leaf spring and extend over an end portion of the base body; upon reverse motion of the movable element, the elongated end cannot, however, slip because of the one-way locking feature, thus retaining the tape or ribbon (25) taut against the opening (34) and effecting a good seal to prevent egress of operating fluid, as well as ingress of contamination, such as dirt, extraneous oil or the like.
Patent DK-0746459-T3 (DK)
Inventor: TOMNEY JOHN
IPC: B29D11/00
Filed: 1995-02-24
Granted: 2000-07-31
Abstract: A process of preparing a lens 1 uses a de-blocking step to remove the lens 1 from a wax mount 7. In the de-blocking step the wax 7 is only partially dissolved so that the lens remains associated with the wax but can be easily removed therefrom. For the de-blocking step, the wax is treated with a terpene under conditions of agitation. <IMAGE>
Patent DK-0762856-T3 (DK)
Inventor: ISRAEL HENRY M
IPC: A61M29/00
Filed: 1995-07-26
Granted: 1999-06-07
Abstract: The stent (30) is formed of a tube having a patterned shape which has first and second meander patterns having axes extending in first and second directions. The first meander patterns can be formed in even and odd first meander patterns. The even and odd first meander patterns are 180 deg. out of phase with each other, and the odd patterns occur between every two even patterns. The second meander patterns are intertwined with the first meander patterns. The first and second directions can be orthogonal to each other. The second meander patterns can also be formed of even and odd patterns.
Patent DK-0782616-T3 (DK)
Inventor: BUI-KHAC TRUNG
IPC: A61K38/48
Filed: 1995-09-21
Granted: 2006-05-22
Abstract: A process for the large-scale production of therapeutic grade thrombin of excellent viral safety and storage-stability is carried out by purification of viricide treated crude thrombin by ion-exchange chromatography on a single column using a sulfalkyl-activated polysaccharide, particularly a non-compressible composite medium of sulfoalkyl-activated dextran and silica particles, as the ion exchange medium and using increasing concentrations of phosphate buffer for elution. After recovery of thrombin in the final eluate, the phosphate buffer is exchanged for a stabilizing formulation buffer, and the stabilized thrombin is subjected to viral filtration and optional dry heat treatment for further viral inactivation. The final product has high specific activity and is obtained in good yield.
Patent DK-0792458-T3 (DK)
Inventor: VIGO-PELFREY CARMEN
IPC: G01N33/542
Filed: 1995-11-13
Granted: 2005-01-31
Abstract: Diagnosis and monitoring of Alzheimer's disease (AD) is aided by: (a) measuring the amount of at least one soluble Abeta (x->= 41) peptide (I) in a test sample; (b) comparing the result with a predetermined amount of the same peptide; and (c) assessing patient status from the difference.
Patent DK-0757036-T3 (DK)
Inventor: LUGLI GABRIELE
IPC: C07C271/02
Filed: 1996-07-04
Granted: 2001-07-16
Abstract: Process for the preparation of N-alkyl substituted metal carbamate solutions characterized in that a water solution of the salt of the metal of which the corresponding carbamate is to be obtained, is reacted with an organic solution, basically consisting of an aprotic solvent and a secondary amine, saturated with carbon dioxide. The above solutions can be used as catalysts in polymerization reactions of unsaturated monomers or for supporting metals on inorganic oxides.
Patent DK-0807151-T3 (DK)
Inventor: GOODHUE GIFFORD K JR
IPC: C09K8/516
Filed: 1996-01-19
Granted: 2000-12-18
Abstract: This invention relates to an earth stabilization fluid and to a method for using such an earth stabilization fluid. This invention uses a continuous phase that has been added to a borehole and a polymer material that forms gel masses having desired functional properties when added to the continuous phase.
Patent DK-0844828-T3 (DK)
Inventor: DOHMEN GERHARD PETER
IPC: A01N37/50
Filed: 1996-07-30
Granted: 2007-03-19
Abstract: PCT No. PCT/EP96/03354 Sec. 371 Date Feb. 17, 1998 Sec. 102(e) Date Feb. 17, 1998 PCT Filed Jul. 30, 1996 PCT Pub. No. WO97/06690 PCT Pub. Date Feb. 27, 1997Fish mycoses and single-cell ectoparasites on fish are controlled using an active compound suitable for inhibiting the mitochondrial respiratory chain at the stage of the b/c1 complex.
Patent DK-0845972-T3 (DK)
Inventor: MAURER KARL-HEINZ
IPC: A61K8/00
Filed: 1996-08-14
Granted: 2002-04-02
Abstract: A mutated subtilisin-type protease that bears at least one mutation in its amino-acid sequence that causes the positive charge to be reduced or the negative charge to be increased in the substrate binding region of the molecule is used in cosmetic products. Such proteases show a surprisingly low skin and mucous membrane irritating potential.
Patent DK-0935469-T3 (DK)
Inventor: MARIN PER
IPC: A61P3/04
Filed: 1997-04-10
Granted: 2003-03-17
Abstract: The invention relates to the use of growth hormone, preferably human growth hormone or analogues thereof for the manufacturing of a medicament for treatment of individuals with the Metabolic syndrome. They include individuals with abdominal/visceral obesity and its metabolic and circulatory consequences including insulin resistance, lipoprotein aberrations and hypertension. The medicament is also used to increase insulin sensitivity and for treatment and prevention of non-insulin dependent diabetes mellitus.
Patent DK-1007566-T3 (DK)
Inventor: ROUGEON FRANCOIS
IPC: A61K38/08
Filed: 1998-02-19
Granted: 2007-01-02
Abstract: The present invention pertains to the use of a peptide molecule consisting in a maturation product of SMR1 (Submandibular rat protein 1) of structural formula QHNPR, as well as the biologically active derivatives of the said peptide, for preventing or treating diseases associated with a mineral ion imbalance in a human or an animal body. More particularly, the present invention relates to the therapeutic use of the above-cited molecules for preventing or treating an hydro-mineral imbalance in organs and tissues such as kidney, bone, dental enamel, dental ivory, gut matrix, pancreas or glandular gastric mucosa. This invention also deals with therapeutic compositions comprising a pharmaceutically active amount of the above-described therapeutic molecules as well as with therapeutic methods using the said therapeutic compositions. Finally, the present invention relates to processes for selecting ligand molecules that possess an agonist or an antagonist biological activity on the target receptor of the QHNPR pentapeptide as well as to the selected ligand molecules themselves.
Patent DK-1054673-T3 (DK)
Inventor: ROGERS GARY A
IPC: A61K31/542
Filed: 1998-12-16
Granted: 2004-07-05
Abstract: Compounds having a certain benzoxazine ring system and their precursors are disclosed which are useful for enhancing synaptic responses mediated by AMPA receptors. Also disclosed are methods for preparing such compounds, and methods for their use in treating subjects suffering from impaired nervous or intellectual functioning due to deficiencies in the number of excitatory synapses or in the number of AMPA receptors. The invention compounds can also be used for the treatment of non-impaired subjects for enhancing performance in sensory-motor and cognitive tasks which depend on brain networks utilizing AMPA receptors and for improving memory encoding.
Patent DK-0967894-T3 (DK)
Inventor: NICHOLSON DAVID
IPC: A01D23/04
Filed: 1999-01-13
Granted: 2003-01-27
Abstract: A machine for removing roots and tops from crops including a pair of counter-rotating rollers spaced apart so as to define a nip therebetween, and means for rotating the rollers characterized in that at least one roller is in the form of a polygonal twisted prism.
Patent ES-2177488-T3 (ES)
Title: Tanque de doble pared, especialmente para almacenar aceite combustible, carburante diesel, aceites lubricantes y aceities hidraulicos.
Inventor: HERRN DIPL-VOLKSWIRT MANFRED R
IPC: B65D90/503
Filed: 2000-03-29
Granted: 2002-12-16
Abstract: Tanque de doble pared, especialmente para almacenar aceite combustible, carburante diesel, aceites lubricantes y aceites hidráulicos, con un recipiente interior (1) de plástico y un recipiente exterior de chapa de acero, en donde el recipiente exterior (2) está provisto de una tapa (6) que contiene aberturas para racores (7) del recipiente interior (1), en el que la tapa (6) del recipiente presenta un collar (8) de forma de U en sección transversal que está asentado sobre el borde superior de la envuelta (3) del recipiente y unido fijamente con dicha envuelta (3), en el que el espacio interior del collar (8) contiene una junta de estanqueidad (9) que obtura el collar (8) contra la envuelta (3) del recipiente de una manera hermética a los gases, en el que un ala (10) del collar (8) que se aplica al lado interior de la envuelta (3) del recipiente está fijamente unida con dicha envuelta (3), y y en e lque están dispuestos sobre los racores (7) unos anillos de presión (14) para aplicar presióna juntas de estanqueidad (15) que rodean a los racores (7) en forma de anillos.
Patent ES-2262468-T3 (ES)
Inventor: KOCH JURGEN DR
IPC: B23K35/22
Filed: 2000-04-29
Granted: 2006-12-01
Abstract: A boron and/or halogen compound based brazing flux contains an activating additive of elementary boron and one or more of Mo Mn, Co, Ni, Pd, Cu and Ag. Inorganic boron and/or halogen compound based flux, for brazing difficultly wettable metals with silver and copper based brazing materials, contains as activating additive (based on total weight of flux) 0.01-10% elementary boron and 0.01-10% one or more of W, Mn, Co, Ni, Pd, Cu and Ag in elemental, alloy or compound form. Independent claims are also included: (i) use of the activating additive described above as wettability improving additive in the above flux; and (ii) a brazing material/flux combination containing the above flux.
Patent ES-2209730-T3 (ES)
Inventor: KUHNEL BERNHARD
IPC: H01R13/64
Filed: 2000-08-07
Granted: 2004-07-01
Abstract: The invention specifies a scoop-proof plug connector system having a connector (1) which has a pair of contact sockets (66, 67) situated in the plug-in projection (3) and a connector housing (2), a mating connector for an igniter, which has a pair of contact pins (51, 52) situated in one plane for insertion into the contact sockets (66, 67), and a coupling piece (30a, 30b) which is situated in the mating connector and has a recess (34), which is complementary to the plug-in projection (3), and an essentially cylindrical sleeve (31). At least one guide shoulder (35, 36; 43, 44) which runs parallel to the insertion direction and essentially over the full height of the sleeve (31) and which projects above the contact pins (51, 52) is integrally formed in the recess (34).  <IMAGE>
Patent ES-2209754-T3 (ES)
Inventor: LIMMER GERD
IPC: F25D17/00
Filed: 2000-12-14
Granted: 2004-07-01
Abstract: The storage device has a cold zone (K) for storage of cold items and a warm zone (W) for storage of warm items, positioned above the cold zone, with refrigerated air supplied to the base of the cold zone and to the separation region between the cold zone and the warm zone. The refrigerated air is extracted from the separation region via at least one vent snorkel (AS1,ASn) extending vertically through the warm zone, which is adjustable in length by forming it in separate sections, each corresponding to the height of a storage layer.
Patent ES-2188499-T3 (ES)
Inventor: LEMAIRE MARC
IPC: B41J5/10
Filed: 2000-01-14
Granted: 2003-07-01
Abstract: The invention concerns optically active polymers, obtainable by polymerizing chiral diphosphine having a C2 axis of symmetry, excluding all other symmetry element, with one or several polymerizable monomers, said chiral diphosphine consisting of a chiral body bearing two identical functional groups capable of reacting with said polymerizable monomers.
Patent ES-2568624-T3 (ES)
Title: Determinación de la concentración y de la viabilidad del esperma para inseminación artificial
Inventor: CHRISTENSEN PREBEN
IPC: G01N15/14
Filed: 2000-03-06
Granted: 2016-05-03
Abstract: Un método para la determinación objetiva de la concentración total de espermatozoides en una muestra de semen y la proporción de espermatozoides vivos en la misma, que comprende someter la muestra de semen, o una submuestra diluida de la muestra de semen, a tinción selectiva, en el que la tinción selectiva comprende un fluorocromo que se une a ADN y que tiñe todos los espermatozoides combinado con un fluorocromo que se une a ADN y que tiñe de forma selectiva los espermatozoides muertos, en el que la muestra o submuestra se combina con un medio estándar de concentración interna, y la determinación de la concentración total de los espermatozoides y la proporción de espermatozoides vivos se realizan de forma simultánea con un medio de detección sensible a la tinción selectiva y al medio de referencia de concentración interna, en el que la determinación de la concentración total de espermatozoides y la proporción de espermatozoides vivos se realizan usando la misma muestra o submuestra y se realizan de forma simultánea en la misma operación de determinación.
Patent ES-2338405-T3 (ES)
Inventor: MERCHAV SHOSHANA
IPC: C12N5/06
Filed: 2000-02-04
Granted: 2010-05-07
Abstract: The present invention concerns a method of preparing a conditioned medium from a confluent stromal cell culture, the method comprising: (a) culturing stromal cells to confluence in a stationary phase plug-flow bioreactor under continuous flow of medium on a three dimensional substrate to obtain a stationary phase three-dimensional confluent stromal cell culture, wherein said stromal cell culture is grown to a density of at least 5 x 10 6  cells per a cubic centimeter of said substrate; and (b) separating and collecting a stromal cell conditioned medium from said stationary phase confluent stromal cell culture; thereby obtaining the conditioned medium.
Patent ES-2241596-T3 (ES)
Title: Produccion de pastillas porosas de polimeros dienicos mediante secado mecanico.
Inventor: MEYER DE GROOT ELEANOR
IPC: C08J9/12
Filed: 2000-04-19
Granted: 2005-11-01
Abstract: Un proceso para el acabado de un copolímero de bloque hidrogenado de un hidrocarburo vinil-aromático y un dieno conjugado mediante la producción de pastillas porosas a partir de una suspensión acuosa del copolímero de bloque hidrogenado, comprendiendo dicho proceso ajustar el contenido de agua de la suspensión a desde 9 a 16 por ciento en peso, pasar la suspensión a través de un secador tipo extrusora mecánica, secar la suspensión a una temperatura de 100 a 180ºC y recuperar las pastillas de copolímero poroso que tienen una porosidad de al menos 0, 4 cm3/g y un contenido en humedad del 0, 2 al 3, 0 por ciento en peso.
Patent ES-2353953-T3 (ES)
Inventor: KLOCKEMANN WERNER
IPC: C07B61/00
Filed: 2000-07-04
Granted: 2011-03-08
Abstract: The invention in question is concerned with a method for the production of triethylene diamine using ethylene diamine as an educt and zeolite catalysts of the Pentasil type.
Patent ES-2202225-T3 (ES)
Title: Enlace de comunicacion hibrido optico y de radio frecuencia sin hilos.
Inventor: WILLEBRAND HEINZ
IPC: H04B10/118
Filed: 2000-12-26
Granted: 2004-04-01
Abstract: Un método de comunicación de datos en un enlace de comunicación (20) que se extiende a través de una región terrestre (30) de espacio libre entre dos estaciones (22, 24) en los extremos del enlace (20), que comprende las operaciones de: comunicar los datos en una señal óptica transmitida a través de un trayecto óptico (26) de espacio libre entre las dos estaciones (22, 24), comunicar información de control y estado en una señal de radiofrecuencia (RF) transmitida a través de un trayecto (28) de RF de espacio libre entre las dos estaciones (22, 24) concurrentemente con la transmisión de la señal óptica que contiene los datos; y comunicar los datos y la información de control y estado en una señal de RF transmitida en el trayecto (28) de RF de espacio libre entre las dos estaciones (22, 24) cuando los datos no son transmitidos en la señal óptica a través del trayecto óptico (26).
Patent ES-2218303-T3 (ES)
Inventor: HOECK ROGER
IPC: A61M5/50
Filed: 2001-05-14
Granted: 2004-11-16
Abstract: A hypodermic syringe (10) with a selectively retractable needle (56) includes an elongate barrel (12) defining a receiver (18) and a hollow bore (20). The syringe has a plunger (22) with an elongate cavity (34) open to the proximal end. The plunger is sized to fit within the bore of the barrel for a slidable movement to define a chamber (36) for receiving and expelling fluids. The inside diameter of the cavity in the plunger is sufficient to accept telescopically at least a part of a first portion (26) of the plunger. A second portion (32) and the first portion are joined at an attachment (38) to form a shoulder (40) extending outwardly from the first portion, with the plunger being telescopically collapsible by movement of the second portion into the cavity by of sufficient distal force to frangibly disrupt the attachment. The syringe includes an elongate sleeve (42) sized to fit over the first portion of the plunger and extend from the shoulder. The plunger includes a stopper (44) to a form fluid tight seal with the barrel. The sleeve has a cutting surface (46) inside of the stopper. The syringe includes a hub (50) with a proximal flange (52) and a passageway (54) within the receiver. The syringe has a needle with a pointed distal end mounted in the passageway of the hub extending distally outwardly. When sufficient distal force is applied to collapse the plunger, the cutting surface of the sleeve cuts through the stopper and through the flange of the hub and releases it from the receiver to retract the needle. <IMAGE>